Have a personal or library account? Click to login
Hypertrophic Lichen Planus – a Case Report Cover
Open Access
|Dec 2014

References

  1. 1. Oliver GF, Winkelmann RK.Treatment of lichen planus. Drug 1993;45(1):56-65.10.2165/00003495-199345010-00006
  2. 2. Wolff K, Johnson RA, Suurmond D. Fitzpatrick`s Color Atlas and Synopsis of Clinical Dermatology. 5th ed. New York: Mc Graw-Hill Medical Pubishing Division; 2005. p. 123-7.
  3. 3. Stanojević M, Paravina M. Eritemoskvamozne dermatoze. U: ParavinaM, Spalević Lj, Stanojević M, Tiodorović J, Binić I, Jovanović D. Dermatovenerologija. 2nd ed. Niš: Medicinsi fakultet; 2006. p. 185-98.
  4. 4. Karadaglić Đ, Pavlović M. Lichen planus i lihenoidne reakcije. U: Karadaglić Đ, editor. Dermatologija. Beograd: Vojnoizdavački zavod; 2000. p. 973-84.
  5. 5. Jaime TJ, Guaraldi Bde M, Melo DF, Jeunon T, Lerer C. Disseminated hypertrophic lichen planus: relevant response to acitretin. An Bras Dematol 2011;86(Suppl 4):S96-9.10.1590/S0365-05962011000700025
  6. 6. Pinter A, Patzold S, Kaufmann R. Lichen planus of nails - successful treatment with Alitretinoin. J Dtsch Dermatol Ges 2011;9(12):1033-4.10.1111/j.1610-0387.2011.07773.x
  7. 7. Staubach P. Lichen planus. CME Dermatol 2009;4(2):68-79.
  8. 8. Zakrzewska JM, Chan ES, Th ornhill MH. A systematic review of placebo - controlled randomized clinical trials of treatments used in oral lichen planus. Br J Dermatol 2005;153(2):336-41.10.1111/j.1365-2133.2005.06493.x
  9. 9. Usatine RP, Tinitigan M. Diagnosis and treatment of lichen planus. Am Fam Physician 2011;84(1):53-60.
  10. 10. Kumar UM, Yelikar BR, Inamadar AG, Umesh S, Singhal A, Kushtagi AV. A clinico-pathological study of lichenoid tissue reactions - a tertiary care experience. J Clin Diagn Res 2013;7(2):312-6.10.7860/JCDR/2013/5110.2755
  11. 11. Wolf R, Ruzicka T, Rupec RA. Pleomorphismus des Lichen ruber - klinische Variationsbreite, Pathogenese und Th erapie. Akt Dermatol 2010;36:180-5.10.1055/s-0029-1214947
  12. 12. Friedl TK, Flaig MJ, Rupec RA. Verrucous squanous cell carcinoma complicating hypetrophic lichen planus. Th ree case reports and review of the literature. Hautarzt 2011;62(1):40-5.10.1007/s00105-010-1961-4
  13. 13. Boyd AS, Neldner KH. Lichen planus. J Am Acad Dermatol 1991;25(4):593-619.10.1016/0190-9622(91)70241-S
  14. 14. Saurat JH, Laugier P. Lichen plan et dermatoses lichenoides. In: Saurat JH, Groshans E, Laugier P, Lachapelle JM. Dermatologie et venereologie. 2nd ed. Paris: Masson; 1990. p. 338-43.
  15. 15. Braun Falco O, Plewig G, Wolff HH, Winkelmann RK, editors. Dermatology. Berlin: Springer Verlag; 1991.10.1007/978-3-662-00181-3
  16. 16. De Yong EM, Van De Kerkhof PC. Coexistence of palmoplantar lichen planus and lupus erythematosus with response to treatment using acitretin. Br J Dermatol 1996;134(3):538-41.10.1111/j.1365-2133.1996.tb16245.x
  17. 17. Tank B, Van Joost T. Lichen planus and graft vs host disease. In: Bos JD, editor. Skin immune system (SIS). Boca Raton: CRC Press; 1997. p. 531-41.
  18. 18. Wenzel J, Scheler M, Proelss J, Bieber T, Tuting T. Type I interferon- associated cytotoxic infl ammation in lichen planus. J Cutan Pathol 2006;33(10):672-8.10.1111/j.1600-0560.2006.00527.x
  19. 19. Wagner G, Rose C, Sachse M. Clinical variants of lichen planus. J Dtsch Dermatol Ges 2013;11(4):309-19.10.1111/ddg.12031
  20. 20. Cocchi R, Giomi A, Tuci F, Bartoli L, Sedhieri G. Pityriasis rubra pilaris, lichen planus, alopecia universalis and vitiligo in patient with chronic viral hepatitis C. Dermatology 1994;188(3):239-40.10.1159/000247149
  21. 21. Benchikhni H, Nejjam F, Habibeddine S, Jarmouni R, Lakhdar H. Lichen planus and hepatitis C. Ann Dermatol Venereol 1994;121(8):547-9.
  22. 22. Arndt KA. Lichen planus. In: Fitzpatrick TB, editor. Dermatology in generale medicine. New York Mc Graw- Hill Book Comp; 1987. p. 967-73.
  23. 23. Marks R. Retinoids in the treatment of lichen planus and lupus erythematodes. Retinoids Today and Tomorrow 1989;16:4-5.
  24. 24. Black MM. Lichen planus and lichenoid disorders. In: Rook`s Textbook of Dermatology. 5thed. Oxford: Blackwel Scientifi c Publ; 1992. p. 1675-98.
  25. 25. Singh SK, Saikia UN, Ajith C, Kumar B. Squamous cell carcinoma arising from hypertrophic lichen planus. J Eur Acad Dermatol Venereol 2006;20(6):745-6.10.1111/j.1468-3083.2006.01500.x
  26. 26. Bromwich M. Retrospective study of the progression of oral premalignant lesions to squamous cell carcinoma: South Wales experiance. J Otolaryngol 2002;31(3):150-6.10.2310/7070.2002.10836
  27. 27. Gandolfo S, Richiardi I, Carrozzo M, Broccoletti R, Carbone M, Pagano M, et al. Risk of oral squamous cell carcinoma in 402 patients with oral lichen planus: a follow-up study in an Italian population. Oral Oncol 2004;40(1):77-83.10.1016/S1368-8375(03)00139-8
  28. 28. Van der Meij EH, Mast H, van der Waal I. Th e possible premalignant character of oral lichen planus and oral lichenoid lesions: a prospective fi ve-year follow-up study of 192 patients. Oral Oncol 2007;43(8):742-8.10.1016/j.oraloncology.2006.09.00617112770
  29. 29. Pindborg JJ, Reichart PA, Smith CJ, van der Waal I. Histo-logical typing of cancer and precancer of theoral mucosa. In: WHO international classifi cation of skin tumors. Berlin: Springer; 1997 . 10.1007/978-3-642-60592-5
  30. 30. Ardabili M, Gambichler T, Rotterdam S, Altmeyer P, Hoff - mann K, Stucker M. Metastatic cutaneous squamous cell carcinoma arising from a previous area of chronic hypertrophic lichen planus. Dermatol Online J 2003;9(1):10.10.5070/D39CF3Q2FK
  31. 31. Sigurgeirsson B, Lindelof B. Lichen planus and malignancy. An epidemiologic study of 2071 patients and review of the literature. Arch Dermatol 1991;127(11):1684-8.10.1001/archderm.1991.01680100084009
  32. 32. Manz B, Paasch U, Sticherling M. Squamous cell carcinoma as a complication of long-standing hypertrophic lichen planus. Int J Dematol 2005;44(9):773-4.10.1111/j.1365-4632.2004.02202.x16135151
  33. 33. Campanati A, Marconi B, Penna L, Giangiacomi M, Offi dani A. A case of hypertrophic lichen ruber planus of the leg complicated by a squamous cell carcinoma. Int J Dermatol 2003;42(5):415-6.10.1046/j.1365-4362.2003.01791.x12755988
  34. 34. Kolios AG, Marques Maggio E, Gubler C, Cozzio A, Dummer R, French LE, et al. Oral, esophageal and cutaneous lichen ruber planus controlled with alitretinoin: case report and review of the literature. Dermatology 2013;226(4):302-10.10.1159/00034998023948733
  35. 35. Thomson MA, Hamburger J, Stewart DG, Lewis HM. Treatment of erosive oral lichen planus with topical tacrolimus. J Dermatolog Treat 2004;15(5):308-14.10.1080/0954663041001824715370399
  36. 36. Sonthalia S, Singal A. Comparative effi cacy of tacrolimus 0.1% ointment and clobetasol propionate 0,05% ointment in oral lichen planus: a randomized double- blind trial. Int J Dermatol 2012;51(11):1371-8.10.1111/j.1365-4632.2012.05459.x23067089
  37. 37. Swift JC, Rees TD, Plemons JM, Hallmon WW, Wright JC. Th e eff ectiveness of 1% pimecrolimus cream in the treatment of oral erosive lichen planus. J Periodontol 2005;76(4):627-35.10.1902/jop.2005.76.4.62715857105
  38. 38. Eisen D, Carrozzo M, Bagan Sebastian JV, Th ongprasom K, Number V. Oral lichen planus: clinical features and management. Oral Dis 2005;11(6):338-49.10.1111/j.1601-0825.2005.01142.x16269024
  39. 39. Dostanić I. Retinoidi u dermatološkoj praksi. Beograd: Dostanić N; 1995. p. 10-4.
  40. 40. Brehmer F, Haenssle HA, Schon MP, Emmert S. Response of recalcitrant lichen planus to alitretinoin i 3 patients. J Am Acad Dermatol 2011;65(2):e58-60.10.1016/j.jaad.2011.02.02321763556
  41. 41. Molin S, Ruzicka T. Oral alitretinon in lichen planus: two case reports. Acta Derm Venereol 2010;90(5):523-4. 10.2340/00015555-078120814633
Language: English
Page range: 73 - 80
Published on: Dec 11, 2014
Published by: Serbian Association of Dermatovenereologists (SAD)
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2014 Mirjana Paravina, published by Serbian Association of Dermatovenereologists (SAD)
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.